free prostate Specific antigen/prostate specific antigen total in serum/plasma

From Aaushi
Jump to navigation Jump to search

Indications

Clinical significance

More general terms

Components

References

  1. Loinc
  2. 2.0 2.1 2.2 Catalona WJ, Partin AW, Slawin KM et al Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA. 1998 May 20;279(19):1542-7. PMID: https://www.ncbi.nlm.nih.gov/pubmed/9605898